Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 4:15:1345756.
doi: 10.3389/fneur.2024.1345756. eCollection 2024.

Behavioral disinhibition in stroke

Affiliations

Behavioral disinhibition in stroke

Wai Kwong Tang et al. Front Neurol. .

Abstract

Background: Post-stroke behavioral disinhibition (PSBD) is common in stroke survivors and often presents as impulsive, tactless or vulgar behavior. However, it often remains undiagnosed and thus untreated, even though it can lead to a longer length of stay in a rehabilitation facility. The proposed study will aim to evaluate the clinical, neuropsychological and magnetic resonance imaging (MRI) correlates of PSBD in a cohort of stroke survivors and describe its 12-month course.

Methods: This prospective cohort study will recruit 237 patients and will be conducted at the Neurology Unit of the Prince of Wales Hospital. The project duration will be 24 months. The patients will be examined by multiple MRI methods, including diffusion-weighted imaging, within 1 week after stroke onset. The patients and their caregivers will receive a detailed assessment at a research clinic at 3, 9 and 15 months after stroke onset (T1, T2 and T3, respectively). The disinhibition subscale of the Frontal Systems Behavior Scale (FrSBe) will be completed by each subject and caregiver, and scores ≥65 will be considered to indicate PSBD.A stepwise logistic regression will be performed to assess the importance of lesions in the regions of interest (ROIs), together with other significant variables identified in the univariate analyses. For patients with PSBD at T1, the FrSBe disinhibition scores will be compared between the groups of patients with and without ROI infarcts, using covariance analysis. The demographic, clinical and MRI variables of remitters and non-remitters will be examined again at T2 and T3 by logistic regression.

Discussion: This project will be the first MRI study on PSBD in stroke survivors. The results will shed light on the associations of lesions in the orbitofrontal cortex, anterior temporal lobe and subcortical brain structures with the risk of PSBD. The obtained data will advance our understanding of the pathogenesis and clinical course of PSBD in stroke, as well as other neurological conditions. The findings are thus likely to be applicable to the large population of patients with neurological disorders at risk of PSBD and are expected to stimulate further research in this field.

Keywords: MRI; anterior temporal lobe; behavior disinhibition; caudate; prefrontal cortex; stroke; thalamus.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Details of recruitment.

Similar articles

References

    1. Knutson KM, Dal Monte O, Schintu S, Wassermann EM, Raymont V, Grafman J, et al. . Areas of brain damage underlying increased reports of behavioral disinhibition. J Neuropsychiatry Clin Neurosci. (2015) 27:193–8. doi: 10.1176/appi.neuropsych.14060126, PMID: - DOI - PMC - PubMed
    1. Gregg N, Arber A, Ashkan K, Brazil L, Bhangoo R, Beaney R, et al. . Neurobehavioral changes in patients following brain tumour: patients and relatives perspective. Support Care Cancer. (2014) 22:2965–72. doi: 10.1007/s00520-014-2291-3 - DOI - PubMed
    1. Srikanth S, Nagaraja AV, Ratnavalli E. Neuropsychiatric symptoms in dementia-frequency, relationship to dementia severity and comparison in Alzheimer’s disease, vascular dementia and frontotemporal dementia. J Neurol Sci. (2005) 236:43–8. doi: 10.1016/j.jns.2005.04.014, PMID: - DOI - PubMed
    1. Shea YF, Ha J, Chu L. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer’s disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic. Psychogeriatrics. (2014) 15:235–41. doi: 10.1111/psyg.12103, PMID: - DOI - PubMed
    1. Litvan I, Mega MS, Cummings JL, Fairbanks L. Neuropsychiatric aspects of progressive supranuclear palsy. Neurology. (1996) 47:1184–9. doi: 10.1212/WNL.47.5.1184, PMID: - DOI - PubMed

LinkOut - more resources